comparemela.com

Latest Breaking News On - Biosciences pte - Page 3 : comparemela.com

Artificial Intelligence in Genomics Market worth $1,671 million by 2025 - Exclusive Report by MarketsandMarkets

Artificial Intelligence in Genomics Market worth $1,671 million by 2025 - Exclusive Report by MarketsandMarkets Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research) - Global Forecasts to 2025 , published by MarketsandMarkets, the global AI in Genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025 Browse in-depth TOC on 141 - Tables Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899 The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medica

United-states
Ireland
Canada
Northbrook
Illinois
Chicago
Belgium
America
Biosciences-pte
Kostenloser-wertpapierhandel
Aashish-mehra
Component-software

Artificial Intelligence in Genomics Market worth $1,671 million by 2025 - Exclusive Report by MarketsandMarkets™

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period. Machine learning to dominate the AI in Genomics market in 2019 Based on technology, the Artificial Intelligence in Genomics Market is segmented into machine learning and other technologies. The machine learning segment dominated this market in 2019, as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug genomics applications. This is because machine learning can extract insights from data sets, accelerating genomic research.

United-states
Ireland
Canada
Northbrook
Illinois
Chicago
Belgium
America
Biosciences-pte
Aashish-mehra
Component-software
Research-centers

VolitionRx Limited announces executive appointments to help drive its Nu.Q commercialization efforts

VolitionRx Limited announces executive appointments to help drive its Nu.Q commercialization efforts
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Belgium
Belgian
Biosciences-pte
Mark-eccleston
Cameron-reynolds
Terig-hughes
Gaetan-michel
Volitionrx-limited
Ucroo-incorporated
Chief-financial-officer
Chief-operating-officer
Gael-forterre

VolitionRx Limited announces executive appointments to help drive its Nu.Q commercialization efforts

VolitionRx Limited announces executive appointments to help drive its Nu.Q commercialization efforts
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Belgium
Belgian
Biosciences-pte
Mark-eccleston
Cameron-reynolds
Terig-hughes
Gaetan-michel
Volitionrx-limited
Ucroo-incorporated
Chief-financial-officer
Chief-operating-officer
Gael-forterre

VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts

VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts News provided by Share this article Share this article AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ( Volition ) today provided a business update and announced the appointment of a new Chief Financial Officer, Mr. Terig Hughes, in addition to the appointment of Dr. Gaetan Michel as Chief Operating Officer, Mr. Gael Forterre as Chief Commercial Officer, and Dr. Mark Eccleston as Chief Technology Officer. A video providing a business update and introducing Volition’s new team members.   Despite the pandemic we achieved a lot throughout 2020 and the momentum has continued into 2021 with a very busy January. We have opened our new manufacturing facility Silver One , announced additional non-dilutive funding of approximately $4 million and presented the first data from our large-scale lung cancer study, commented Cameron Reynolds, President a

United-states
Paris
France-general
France
United-kingdom
Texas
Singapore
Belgium
California
San-diego
London
City-of

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.